A Phase 1, Randomized, Double-Blind, Placebo- and Positive-Controlled Study to Evaluate the Effect of Ozanimod on Pressor Response to Oral Tyramine in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 22 Jul 2019
Price : $35 *
At a glance
- Drugs Ozanimod (Primary) ; Phenelzine; Tyramine
- Indications Crohn's disease; Multiple sclerosis; Ulcerative colitis
- Focus Pharmacodynamics
- Sponsors Celgene Corporation
- 17 Jul 2019 Status changed from recruiting to completed.
- 19 Oct 2018 Planned End Date changed from 5 Mar 2019 to 8 Jan 2019.
- 19 Oct 2018 Planned primary completion date changed from 6 Jan 2019 to 8 Jan 2019.